Refining the Definitions of Biochemical and Clinical Cure for Primary Aldosteronism Using the Primary Aldosteronism Surgical Outcome (PASO) Classification System
Sign Up to like & getrecommendations! Published in 2017 at "World Journal of Surgery"
DOI: 10.1007/s00268-017-4311-1
Abstract: IntroductionDetermination of outcomes after adrenalectomy for primary aldosteronism (PA) is limited by the lack of standardized definitions of cure. The Primary Aldosteronism Surgical Outcomes (PASO) group recently established new consensus definitions for biochemical and clinical… read more here.
Keywords: aldosteronism; primary aldosteronism; paso; biochemical clinical ... See more keywords
Evaluation of Clinical, Gram Stain, and Microbiological Cure Outcomes in Men Receiving Azithromycin for Acute Nongonococcal Urethritis: Discordant Cures Are Associated With Mycoplasma genitalium Infection
Sign Up to like & getrecommendations! Published in 2021 at "Sexually Transmitted Diseases"
DOI: 10.1097/olq.0000000000001509
Abstract: Resolution of nongonococcal urethritis signs and symptoms does not always correlate with microbiological cure; discordant cures occur in one-third of men. Clinical cure accurately correlates with Gram stain and microbiological cure for nongonococcal urethritis bacterial… read more here.
Keywords: microbiological cure; clinical cure; mycoplasma genitalium; cure ... See more keywords
Selective treatment of nonsevere clinical mastitis does not adversely affect cure, somatic cell count, milk yield, recurrence, or culling: A systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of dairy science"
DOI: 10.3168/jds.2022-22271
Abstract: Treatment of clinical mastitis (CM) contributes to antimicrobial use on dairy farms. Selective treatment of CM based on bacterial diagnosis can reduce antimicrobial use, as not all cases of CM will benefit from antimicrobial treatment,… read more here.
Keywords: cell count; selective treatment; somatic cell; clinical cure ... See more keywords
Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.892031
Abstract: Objective To explore dynamic changes of cytokines and virological markers associated with hepatitis B surface antigen (HBsAg) loss during peginterferon alpha-2a (PEG-IFN α-2a) treatment in hepatitis B e antigen (HBeAg) positive chronic hepatitis B (CHB)… read more here.
Keywords: cure group; clinical cure; hepatitis; cure ... See more keywords
Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.997608
Abstract: Currently, interferon add-on therapy brings hope for clinical cure of chronic hepatitis B patients with low HBsAg. However, in clinical practice patients with poor responses to their first interferon therapy were often switched to nucleos(t)ide… read more here.
Keywords: add therapy; interferon experienced; therapy; clinical cure ... See more keywords
Development and validation of a clinical cure marker based on negative lymph nodes for gastric cancer after gastrectomy
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Surgery"
DOI: 10.3389/fsurg.2023.1016252
Abstract: Objective To explore lymph node (LN)-related derived indicators as clinical cure markers for gastric cancer (GC) after gastrectomy. Methods Data of resected GC patients were extracted from the SEER database and our own department. Propensity… read more here.
Keywords: marker; clinical cure; gastric cancer; cure ... See more keywords